A Pilot Study of Chemoradiotherapy Plus Temsirolimus (Torisel) for Advanced Head and Neck Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Cetuximab; Cisplatin; Temsirolimus
- Indications Head and neck cancer
- Focus Adverse reactions
- 14 Feb 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 04 Apr 2011 New trial record